1 “From microscope to management” Dr Mark Newbold CEO, Heart of England NHS FT web:
today... my journey into management CEO perspective on pathology and future questions / discussion
my journey - training graduated from Birmingham Uni house jobs - Dudley Rd Hosp & QEH SHO pathology - General & Childrens Reg in Histopathology - Warwick Hosp Lecturer in Pathology, Med Sch Consultant at Warwick Hospital 1989 MRCPath 1991 MD
my journey - post-training Consultant at Warwick Hospital Head of Cytology / Postgraduate Clinical Tutor / Clinical Director of Pathology ISM Mgt training / Dip. BA at Warwick Business School Consultant at Walsgrave / UHCW Clinical Director of Pathology / Head of Division / Associate Medical Director Managing Director, Rugby St Cross Hospital Led Cov & Warks Acute Services Review for SHA Aspiring CEO programme, West MIdlands SHA left clinical work for CEO post Board post
some reflections... build skills base in your own specialty moving outside pathology is a key step take lots of advice - mentor / coach / or just ask! delegate - encourage, support, don’t always do! there is no ‘black book’ it’s all about people don’t try to conform to management stereotype - understand what is needed and deliver it your way
The real challenges! persisting health inequalities care quality - especially elderly care variable / poor clinical outcomes money - (£20bn) Nicholson challenge outmoded approach to chronic illness politics, esp. around ‘local’ services
key issues for provider CEO? clinical outcomes patient satisfaction targets - performance and quality financial balance governors / local issues QIPP / £20bn challenge shift from hospital to community / home care
what would CEOs like from you? guidance and advice clear clinical planning / strategy creation of clinical consensus constructive involvement in ‘real world’ debate on resource / constraints leadership on outcomes and quality
future of pathology… Nicholson challenge / economic outlook Future of smaller hospitals / specialist services Carter report - £500m efficiencies via rationalising? GP direct access c50% work for most labs, with significant surplus – ie it subsidises hospital lab service No real issues re quality / service standards
predictions... Split of hospital and GP/direct access pathology Some reconfiguration of hospital services as result Centralised processing for Cellular Path? What about the consultants?? Specialist clinical services Telepathology Where / How will bright young people like yourselves want to work?